Compare NSPR & ACFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSPR | ACFN |
|---|---|---|
| Founded | 2005 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.4M | 46.1M |
| IPO Year | 2009 | 2006 |
| Metric | NSPR | ACFN |
|---|---|---|
| Price | $0.85 | $19.03 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 87.8K | 51.5K |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | $2,310,000.00 | ★ $4,350,000.00 |
| Revenue This Year | $57.98 | N/A |
| Revenue Next Year | $95.41 | N/A |
| P/E Ratio | ★ N/A | $213.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $12.42 |
| 52 Week High | $2.57 | $31.88 |
| Indicator | NSPR | ACFN |
|---|---|---|
| Relative Strength Index (RSI) | 50.26 | 48.98 |
| Support Level | $0.66 | $16.33 |
| Resistance Level | $1.00 | $19.64 |
| Average True Range (ATR) | 0.08 | 1.27 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 15.53 | 39.84 |
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. The company operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.